INCY : Analysis & Opinions

  1. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  2. AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst ...

    January 14, 2015
    AstraZeneca (AZN) announced a deal with a privately held biotechnology company, Omnis Pharmaceuticals.
  3. Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics ...

    January 14, 2015
    Preliminary fourth quarter results and expectations for 2015 were key highlights in the biotech sector.
  4. A Company's First Profit Can Mean Big Profits to Investors - ...

    January 12, 2015
    A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week
  5. Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst ...

    January 12, 2015
    Agenus (AGEN) inked a global license, development and commercialization agreement with Incyte Corporation for the development ...
  6. AbbVie 2015 Earnings Guidance Projects Strong Y/Y Growth - Analyst ...

    January 9, 2015
    AbbVie (ABBV) announced that it expects earnings in the range of $4.25 to $4.45 per share for 2015.
  7. Alexion Reports Disappointing Phase II Data on Soliris - Analyst ...

    January 8, 2015
    Alexion Pharmaceuticals, Inc. reported disappointing data from a phase II study evaluating Soliris for the prevention of ...
  8. Biodel Posts Positive Preliminary Data on its Diabetes Drug - ...

    January 8, 2015
    Biodel Inc. (BIOD) announced positive preliminary data from a phase IIa study on its diabetes candidate, BIOD-531.
  9. Alkermes Soars on Positive Schizophrenia Drug Results - Analyst ...

    January 8, 2015
    Alkermes (ALKS) reported positive top-line data from a mid-stage study on its experimental schizophrenia treatment, ALKS ...
  10. Eli Lilly Maintains '14 View, Growth to Resume in 2015 - Analyst ...

    January 8, 2015
    Eli Lilly (LLY) provided an overview of its plans to enhance revenue and expand margins. It also issued the financial guidance ...
  11. Alkermes Gains on Positive Depression Drug Study Data - Analyst ...

    January 7, 2015
    Alkermes (ALKS) reported positive top-line results from the FORWARD-1 study on its major depressive disorder candidate, ALKS ...
  12. Gilead to Purchase Liver Disease Program from Phenex - Analyst ...

    January 7, 2015
    Gilead Sciences, Inc. announced that it has entered into an agreement with Phenex Pharmaceuticals.
  13. Celsion Submits Study Protocol for Oncology Candidate - Analyst ...

    January 7, 2015
    Celsion Corporation (CLSN) announced that it has submitted a phase I study protocol for GEN-1 to the FDA.
  14. Incyte Corporation (INCY): New Analyst Report from Zacks Equity ...

    January 7, 2015
    Incyte got a huge boost when Jakafi, the company's only approved product, was approved for an additional indication, polycythemia ...
  15. Minerva Neurosciences' MIN-301 Positive in Primate Study - Analyst ...

    January 6, 2015
    Minerva Neurosciences, Inc. (NERV) announced positive results from the Primomed study in non-human primates on its investigational ...
  16. Immunomedics' Breast Cancer Drug Gets Fast Track Status - Analyst ...

    January 6, 2015
    Immunomedics, Inc.'s (IMMU) sacituzumab govitecan has received fast track status from the FDA for triple-negative breast ...
  17. Salix CEO to Step Down, Inventory Issues Remain in Focus - Analyst ...

    January 6, 2015
    Salix Pharmaceuticals' (SLXP) President and CEO, Carolyn Logan, has decided to step down from its position by the end of ...
  18. Amgen Upgraded to Strong Buy; is it in Your Portfolio? - Analyst ...

    January 5, 2015
    On Jan 3, Zacks Investment Research upgraded Amgen (AMGN) to a Zacks Rank #1 (Strong Buy).
  19. Bull of the Day: Incyte (INCY) - Bull of the Day

    January 1, 2015
    Bull of the Day: Incyte (INCY) - Bull of the Day
  20. Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day

    December 18, 2014
    Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
  21. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  22. Sectors To Watch For An Expected Bullish Week

    November 18, 2013
    If the market continues to push this higher, these two sectors will likely be top performers again. The uptrend remain is ...
  23. Incyte Corporation and Other Nasdaq Stocks Making Big Moves

    August 2, 2012
    The market is off to a rough start. After this morning's trading, the Nasdaq is down 0.4%, the S&P 500 has decreased ...
  24. A Dull ASCO And The Usual Sell-Off

    June 7, 2011
    Investors shouldn't be spooked by the normal post-ASCO sell-off
  25. Abbott Labs Showing Meaningful Growth

    October 21, 2010
    Abbott might just be the best healthcare stock today.
  26. Pharmaceuticals With Big Returns

    June 22, 2010
    These intriguing Pharmaceuticals currently have big returns.
  27. Biotech Stocks Looking Strong

    March 9, 2010
    Biotech Stocks Looking Strong
  28. Why You Should Never Chase a Stock

    April 16, 2007
    With the massive move in Dendreon over the past few days, you may be tempted to chase the stock; here's why you shouldn't.
Trading Center